Immunovia provides further positive data from the VERIFI study of its next-generation pancreatic cancer test
Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced additional results from the successful VERIFI study of its next-generation pancreatic cancer test, ...
Hosted on MSN11mon
Immunovia debuts results for its next gen pancreatic cancer diagnostic
with the company saying that the test was significantly more accurate than CA19-9, the biomarker commonly used to detect pancreatic cancer. Additionally, Immunovia has said that its new test opens ...
Healio13d
Novel blood test could be first step to early detection of pancreatic cancer
A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...
Immunovia AB: Immunovia provides further positive data from the VERIFI study of its next-generation pancreatic cancer test
Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced additional results from the successful VERIFI study of its next-generation pancreatic cancer ...